Vortero is an antifungal medication used to treat a variety of fungal infections, particularly those caused by Aspergillus species and Candida species. It is part of the triazole class of antifungals and works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes.
Vortero is primarily indicated for the treatment of:
Vortero is available in both oral and intravenous formulations. Dosage and administration depend on the specific infection being treated and the patient's overall health status.
Common side effects may include:
Serious side effects can include liver toxicity and skin reactions. It is important to monitor liver function during treatment.
Vortero is contraindicated in patients with known hypersensitivity to voriconazole or any component of the formulation. Caution is advised in patients with liver disease or those taking medications that may interact with voriconazole.
The safety of Vortero in pregnant or breastfeeding women has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant.
If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
For more detailed information about Vortero, including clinical studies and patient experiences, consult your healthcare provider or refer to the official prescribing information.